https://groww.in/blog/syngene-international-makes-strategic-foray-into-us-biologics-manufacturing
Syngene International acquires its first US biologics facility for $36.5M, expanding its global footprint in biopharma manufacturing. Learn more about its...
syngene internationalmakesstrategicforayus